NCT06067035Not yet recruitingNot Applicable
Imaging of Small-vessel Liver Tumours
Assistance Publique - Hôpitaux de Paris0 sites20 target enrollmentStarted: October 1, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 20
- Primary Endpoint
- Imaging findings
Study Overview
Brief Summary
Small-vessel hepatic tumor is a new tumor entity of vascular origin, described in 2016 by Gill et al, in a series of 17 patients. This rare lesion is difficult to diagnose on imaging because it shares a common radiological semiology with several other differential diagnoses ranging from benign hepatic angioma to more aggressive lesions such as angiosarcoma.
Detailed Description
The aim of our study is to enable the imaging diagnosis of a new entity: small vessel hepatic tumor in order to improve diagnostic management.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Histological evidence of a small vessel hepatic tumor either on biopsy or surgical specimen
- •Cross-sectional imaging before the biopsy or pre-operatively (CT, MRI)
Exclusion Criteria
- •Patient under guardianship or curators
Outcomes
Primary Outcomes
Imaging findings
Time Frame: 12 months
Aspect on US Ultrasound Scan (US)
Secondary Outcomes
- Biology(12 months)
- Pathological examination(12 months)
Investigators
Similar Trials
Recruiting
Phase 2
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment10019815liver cancerNL-OMON32482eids Universitair Medisch Centrum28
Active, not recruiting
Not Applicable
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment - everolimus and capecitabine for HCCEUCTR2008-003972-23-NLMC
Completed
Not Applicable
Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence.A potential implication for salvage liver transplantatioC22.0Liver cell carcinomaDRKS00024062Allgemein-, Viszeral- u. Transplantationschirurgie Universitätsmedizin Mainz37
Completed
Phase 2
A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular MelanomaMelanomaNCT00062933National Cancer Institute (NCI)40
Unknown
Not Applicable
Hepatic Arteriography in Liver Cancer Diagnosis and Staging ApplicationsHepatoCellular CarcinomaNCT02936856Guangxi Medical University200